Literature DB >> 11379440

The Idikan adult mortality study.

M C Asuzu1, O O Johnson, E T Owoaje, J S Kaufman, C Rotimi, R S Cooper.   

Abstract

The Idikan adult mortality study is designed to explore the usefulness of the verbal autopsy methodology in the determination of cause-specific adult mortality. Such data have been largely unavailable in developing countries. Members of a stable urban community (4333 adults) were registered in their family units and followed up every 3 months to ascertain deaths, exits and new entries to the study population. Deaths were investigated by means of a verbal autopsy, which was administered by a trained interviewer to the relative closest to the decedent. Two physicians independently studied the results and assigned a cause of death, and these were then confirmed or resolved by a senior physician colleague. Hospitals where deaths occurred were visited and assignable cause of death was obtained where available and compared with the cause assigned by verbal autopsy. Only 8 of the 60 investigated deaths were confirmed to have occurred in a hospital in the first 2 years of the study. The cause of death assigned by verbal autopsy agreed moderately both between the independent coders as well as with the hospital assigned cause of death using the Kappa statistics for agreement beyond chance. We therefore concluded that verbal autopsies appear moderately useful for adult death statistics (Kappa = 0.23 to 0.1). Accumulation of more hospital deaths is needed, however, to make more definite conclusions about the validity of the technique.

Entities:  

Mesh:

Year:  2000        PMID: 11379440

Source DB:  PubMed          Journal:  Afr J Med Med Sci        ISSN: 0309-3913


  5 in total

1.  Research into health, population and social transitions in rural South Africa: data and methods of the Agincourt Health and Demographic Surveillance System.

Authors:  Kathleen Kahn; Stephen M Tollman; Mark A Collinson; Samuel J Clark; Rhian Twine; Benjamin D Clark; Mildred Shabangu; Francesc Xavier Gómez-Olivé; Obed Mokoena; Michel L Garenne
Journal:  Scand J Public Health Suppl       Date:  2007-08       Impact factor: 3.021

2.  Verbal autopsy completion rate and factors associated with undetermined cause of death in a rural resource-poor setting of Tanzania.

Authors:  Mathew A Mwanyangala; Honorathy M Urassa; Jensen C Rutashobya; Chrisostom C Mahutanga; Angelina M Lutambi; Deodatus V Maliti; Honorati M Masanja; Salim K Abdulla; Rose N Lema
Journal:  Popul Health Metr       Date:  2011-08-05

Review 3.  A systematic overview of prospective cohort studies of cardiovascular disease in sub-Saharan Africa.

Authors:  Andre Pascal Kengne; Lucas M Ntyintyane; Bongani M Mayosi
Journal:  Cardiovasc J Afr       Date:  2011-09-07       Impact factor: 1.167

4.  Using verbal autopsy to measure causes of death: the comparative performance of existing methods.

Authors:  Christopher J L Murray; Rafael Lozano; Abraham D Flaxman; Peter Serina; David Phillips; Andrea Stewart; Spencer L James; Alireza Vahdatpour; Charles Atkinson; Michael K Freeman; Summer Lockett Ohno; Robert Black; Said Mohammed Ali; Abdullah H Baqui; Lalit Dandona; Emily Dantzer; Gary L Darmstadt; Vinita Das; Usha Dhingra; Arup Dutta; Wafaie Fawzi; Sara Gómez; Bernardo Hernández; Rohina Joshi; Henry D Kalter; Aarti Kumar; Vishwajeet Kumar; Marilla Lucero; Saurabh Mehta; Bruce Neal; Devarsetty Praveen; Zul Premji; Dolores Ramírez-Villalobos; Hazel Remolador; Ian Riley; Minerva Romero; Mwanaidi Said; Diozele Sanvictores; Sunil Sazawal; Veronica Tallo; Alan D Lopez
Journal:  BMC Med       Date:  2014-01-09       Impact factor: 8.775

5.  Feasibility of a cardiovascular cohort in a Sub-Saharan Africa community: preliminary report of the pilot project TAHES (Tanvè Health Study) in Benin.

Authors:  Yessito Corine Houehanou; Carmelle Mizéhoun-Adissoda; Salimanou Amidou; Iléana Désormais; Martin Houénassi; Pierre-Marie Preux; Benoit Marin; Dismand Houinato; Philippe Lacroix
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.